![Robert J. Towarnicki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert J. Towarnicki
Företagsledare/Principal på
Biotechnology Innovation Organization
Profil
Robert J.
Towarnicki currently works at Biotechnology Innovation Organization, as Member.
Mr. Towarnicki also formerly worked at Cell Pathways, Inc., as Chief Executive Officer, Nucleonics, Inc., as President & Chief Executive Officer from 2003 to 2009, SIRPant Immunotherapeutics, Inc., as President, Chief Executive Officer & Director, Merck & Co., Inc., as Principal, Integra LifeSciences Holdings Corp., as Principal, Collagen Corp., as Vice President, Quest Diagnostics Infectious Disease, Inc., as General Manager, and Pfizer Pharmaceuticals, Inc., as Operations Manager.
Mr. Towarnicki received his undergraduate degree and graduate degree from Villanova University.
Aktiva positioner av Robert J. Towarnicki
| Företag | Position | Start |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Företagsledare/Principal | - |
Tidigare kända positioner av Robert J. Towarnicki
| Företag | Position | Slut |
|---|---|---|
SIRPant Immunotherapeutics, Inc.
 SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Verkställande Direktör | 2024-08-01 |
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA interference-based therapeutics | President | 2009-12-04 |
| MERCK & CO., INC. | Företagsledare/Principal | - |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Verksamhetschef | - |
Collagen Corp.
 Collagen Corp. BiotechnologyHealth Technology Develops biomedical products from mammali | Företagsledare/Principal | - |
Robert J. Towarnickis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
89
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Integra LifeSciences Holdings Corp.
 Integra LifeSciences Holdings Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices, implants and biomaterials | Health Technology |
Cell Pathways, Inc.
 Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat cancer | Health Technology |
Nucleonics, Inc.
Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA interference-based therapeutics | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Collagen Corp.
Collagen Corp. BiotechnologyHealth Technology Develops biomedical products from mammali | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quest Diagnostics Infectious Disease, Inc.
 Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Provides diagnostic services | Commercial Services |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Health Technology |
